Patents by Inventor Torben Nissen

Torben Nissen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • G-CSF conjugates
    Publication number: 20050095684
    Abstract: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.
    Type: Application
    Filed: December 3, 2004
    Publication date: May 5, 2005
    Inventors: Torben Nissen, Kim Andersen, Christian Hansen, Jan Mikkelsen, Hans Schambye
  • Alpha-amylase mutants
    Publication number: 20050084937
    Abstract: The invention relates to a variant of a parent Termamyl-like ?-amylase, which exhibits an alteration in at least one of the following properties relative to said parent ?-amylase: i) improved pH stability at a pH from 8 to 10.5; and/or ii) improved Ca2+ stability at pH 8 to 10.5, and/or iii) increased specific activity at temperatures from 10 to 60° C.
    Type: Application
    Filed: November 4, 2004
    Publication date: April 21, 2005
    Applicant: Novozymes A/S
    Inventors: Torben Borchert, Allan Svendsen, Carsten Andersen, Bjarne Nielsen, Torben Nissen, Soren Kjaerulff